FDA Inspection
Chongqing Southwest No 2 Pharmaceutical Factory Co., LtdChongqing Southwest No 2 Pharmaceutical Factory Co., Ltd – FDA Inspection, Apr 28, 2017
Record Details
This FDA Inspection record concerns Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd, with an inspection on April 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 28, 2017
- Product Type
- Drugs
View Company Profile
ID · 4330cf6e-8453-4f85-b122-5f6257657210
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1021732
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| July 19, 2012 | NAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd
- FDA Inspection 1243715 - 2024-05-31
- FDA Inspection 985510 - 2016-07-28
- FDA Inspection 794375 - 2012-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.